AstraZeneca
AstraZeneca is a global biopharmaceutical company known for its innovative medicines, particularly in the fields of oncology, cardiovascular, renal, and respiratory diseases. Recently, the company announced a significant investment of $2.5 billion to establish a global strategic research and development center in Beijing.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Costa Rica | 1 | 6.00 | 0.09% | +0% | 5,094,118 | 4,556 | $62,000 | 55$ |
| Totals | 1 | 5,094,118 | 4,556 | $62,000 | 55$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Costa Rica:
AstraZeneca announced multimillion-dollar investments in the United States, committing to reduce their fees in exchange for tariff exemptions.
6
China:
AstraZeneca announced an additional investment of $136 million to expand its production capacity in Qingdao.
7
Russia:
AstraZeneca insists on the legality of its existing patent and its rights to the drug.
6
China:
AstraZeneca announced a $2.5 billion investment plan to establish a global strategic R&D center in Beijing.
9
Hong Kong:
AstraZeneca announced an investment of $2.5 billion to establish a global strategic R&D center in Beijing.
7